Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

JULY 18, 2023

The recently proposed bipartisan bill pledges $75 million towards research into the therapeutic potential of psychedelic substances in treating post-traumatic stress disorder (PTSD). The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. In a bold and unprecedented move, U.S.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Thanks to an ever increasing interest in the medical benefits of cannabis, a study was recently conducted that researched the acute effects of cannabis on the symptoms of OCD.

Research and Development 98

Research and Development Consumption Patients Strains 98

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 81

Research and Development Conditions Data Patients 81

Veriheal

MAY 18, 2023

Chronic pain —a condition that affects 50.2 New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

LifeCannMD

APRIL 28, 2025

Scientists had published legitimate research findings showing that cannabis compounds had actually slowed tumor growth in mice. For an engineer like Rick, who understood the value of evidence and data, it was a revelation. He developed a concentrated oil from the cannabis plant and decided to try it on himself.

History 82

History Chronic Pain Research and Development Oil 82

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Pharmaceutical 76

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

LifeCannMD

MAY 27, 2025

Researchers followed chronic pain patients and found something fascinating: the group using just 2.5 A leading researcher in cannabis medicine documented something fascinating called the “biphasic effect.” With cannabis, we’re talking about tiny amounts maybe 1 to 5 milligrams of THC, sometimes even less.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JUNE 5, 2021

On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

The Cannigma

JULY 1, 2021

The study was developed by People Science , a tech-enabled science company that is focused on connecting “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines,” according to People Science. One of the tools to try to tackle sleep and wellness”.

Sleep 119

Sleep Edibles Research and Development Data 119

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

FloridaMarijuana.net

SEPTEMBER 24, 2018

These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. Patients should speak with their certified medical marijuana physician to determine which strains and methods of consumption are most appropriate for their medical conditions.

Terpenes 162

Terpenes Oil Strains Research and Development 162

The Cannigma

NOVEMBER 11, 2021

Published in the Journal of Clinical Psychopharmacology in September 2021, researchers concluded that CBD could lessen the psychoactive effects of THC when taken together. These conditions are aimed to control any factors that might influence the results, also known as confounding variables. CBD alters the subjective effects of THC.

CBD 141

CBD Research and Development THC Environment 141

Veriheal

FEBRUARY 9, 2023

Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs. While comfy MRIs are not its primary goal, this psychedelic research has provided solid preliminary evidence that the psychoactive compound found in magic mushrooms can help accomplish just that.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 111

Consumption Patients Research and Development Data 111

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions.

Terpenes 145

Terpenes Cannabinoids Topical Research and Development 145

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 145

Research and Development Treatment Chronic Pain Sleep 145

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Still, research is ongoing.

Patients 107

Patients Clinical Trials Research and Development Treatment 107

Veriheal

AUGUST 17, 2022

Researchers wanted to evaluate the potential association between cannabis use and respiratory-related emergency room visits and hospitalizations. Data that’s been published on the subject have been contradictory. Not only does the research itself need to be unbiased, but so does the included background information on the subject.

Research and Development 105

Research and Development Topical Data Cannabis 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. The team also suggests that legalization at federal levels will allow for more comprehensive research and results. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

JUNE 29, 2021

Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Forward-Looking Statement Disclaimer.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

JUNE 1, 2021

The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. has emerged as the largest producer and exporter of legalized cannabis for medical and research applications.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

AUGUST 15, 2022

This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels. The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Cannabis 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JULY 28, 2021

Andy served as University of Alberta Associate Vice President (Research) and was a member of the Scientific Advisory Board of the CIHR Institute of Neuroscience Mental Health & Addiction from 2012-2016. With his research and insight, Dr. Greenshaw has held many roles within the greater community.

Research and Development 105

Research and Development Events Media Data 105

Veriheal

NOVEMBER 21, 2023

Scientific research supports the potential of cannabinoids in regulating blood sugar levels, weight management, and addressing diabetic neuropathy. Maya worked with a group of her peers to develop the buddie Bluetooth cannabis bowl.

Research and Development 110

Research and Development Consumption Education Data 110

Cannabis Law Report

FEBRUARY 23, 2022

Provides a conditional adult-use cultivator license to process and distribute cannabis flower products without holding an adult-use processor or distributor license; provides a conditional adult-use processor license to process and distribute cannabis products; provides for the repeal of certain provisions upon the expiration thereof.

Legislation 105

Legislation Conditions Cultivation Agriculture 105